日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Depleting HIF‑1α attenuates the progression of osteosarcoma, but tumorigenicity is sustained through HIF‑independent pathways

抑制HIF-1α可减缓骨肉瘤的进展,但肿瘤发生仍可通过非HIF依赖性途径维持。

Kunishima, Ayaka; Shimizu, Takatsune; Takimoto, Tetsuya; Sagara, Atsunobu; Nobusue, Hiroyuki; Hasuwa, Hidetoshi; Hasegawa, Shinya; Tamaoki, Yuka; Miyake, Hitomi; Fukuchi, Yumi; Saya, Hideyuki; Muto, Akihiro

Association of family pharmacist continuity with patient-reported satisfaction in patients with metastatic cancer: a nationwide cross-sectional study

家庭药剂师连续性与转移性癌症患者患者满意度之间的关联:一项全国性横断面研究

Sagara, Atsunobu; Watanabe, Tomofumi; Abe, Tomoya; Shimizu, Takatsune; Shirozu, Shunsuke; Terakado, Hiroyuki

Experience-based ambivalence toward medical opioid use among Japanese adults: a nationwide cross-sectional survey using the barriers questionnaire II

日本成年人对医用阿片类药物使用的经验性矛盾心理:一项采用障碍问卷II的全国横断面调查

Watanabe, Tomofumi; Sagara, Atsunobu; Abe, Tomoya; Kudoh, Hiroshi; Yoshikawa, Satoshi; Ishimura, Atsushi; Terakado, Hiroyuki

Safety study on switching from intravenous to fixed‑dose subcutaneous formulation of pertuzumab and trastuzumab

帕妥珠单抗和曲妥珠单抗从静脉注射转换为固定剂量皮下注射制剂的安全性研究

Abe, Tomoya; Sagara, Atsunobu; Suzuki, Takayuki; Okada, Daichi; Takei, Daisuke; Matsuzaka, Kazumasa; Kobayashi, Honoka; Hiraide, Makoto; Sano, Motohiko; Nakayama, Toshiaki

Pharmacist Awareness, Knowledge, and Clinical Engagement of Medication-Related Osteonecrosis of the Jaw: A Survey From a Designated Community Cancer Care Hospital

药剂师对药物相关性颌骨坏死的认知、知识和临床参与度:来自指定社区癌症护理医院的一项调查

Sano, Motohiko; Iijima, Yosuke; Watanabe, Saya; Sagara, Atsunobu; Ushikubo, Kenta; Yamada, Miki; Ohya, Hiroyuki; Morimoto, Mashu; Horie, Norio; Kaneko, Takahiro

Cross-sectional survey on cancer patients' concerns and consultation needs with pharmacists at the time of initial diagnosis

一项关于癌症患者在初次诊断时对药剂师的关注点和咨询需求的横断面调查

Watanabe, Tomofumi; Sagara, Atsunobu; Abe, Tomoya; Komuro, Masato; Yubune, Koharu; Yoshikawa, Satoshi; Terakado, Hiroyuki

Single‑agent nintedanib suppresses metastatic osteosarcoma growth by inhibiting tumor vascular formation.

单药尼达尼布通过抑制肿瘤血管形成来抑制转移性骨肉瘤的生长

Shimizu Takatsune, Sagara Atsunobu, Fukuchi Yumi, Muto Akihiro

Risk factors for nausea and vomiting requiring the daily administration of 5-HT(3) receptor antagonists in radiotherapy combined with temozolomide for high-grade glioma

高级别胶质瘤放疗联合替莫唑胺治疗中,需要每日服用5-HT(3)受体拮抗剂的恶心呕吐风险因素

Takagi, Mai; Sagara, Atsunobu; Kumakura, Yasuo; Watanabe, Minako; Inoue, Rikako; Miyazaki, Masayuki; Ohka, Fumiharu; Motomura, Kazuya; Natsume, Atsushi; Wakabayashi, Toshihiko; Saito, Ryuta; Yamada, Kiyofumi

Development of a novel drug information provision system for Kampo medicine using natural language processing technology

利用自然语言处理技术开发一种新型的汉方药信息提供系统

Maeda-Minami, Ayako; Yoshino, Tetsuhiro; Yumoto, Tetsuro; Sato, Kayoko; Sagara, Atsunobu; Inaba, Kenjiro; Kominato, Hidenori; Kimura, Takao; Takishita, Tetsuya; Watanabe, Gen; Nakamura, Tomonori; Mano, Yasunari; Horiba, Yuko; Watanabe, Kenji; Kamei, Junzo

Impact of lenvatinib-induced proteinuria and renal dysfunction in patients with thyroid cancer

乐伐替尼诱导的蛋白尿和肾功能障碍对甲状腺癌患者的影响

Shibutani, Yuma; Suzuki, Shinya; Sagara, Atsunobu; Enokida, Tomohiro; Okano, Susumu; Fujisawa, Takao; Sato, Fumiaki; Yumoto, Tetsuro; Sano, Motohiko; Kawasaki, Toshikatsu; Tahara, Makoto